These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 6539460)

  • 1. Evaluation of chemotherapy in a murine model for bladder cancer.
    Murphy GP; Pontes JE; Williams PD
    Oncology; 1984; 41(3):195-9. PubMed ID: 6539460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A murine model for bladder cancer.
    Murphy GP; Sandberg AA; Pontes JE; Ochi H; Yoshida M; Williams PD
    Prog Clin Biol Res; 1984; 162A():177-200. PubMed ID: 6541340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravesical and systemic chemotherapy of murine bladder cancer.
    Soloway MS
    Cancer Res; 1977 Aug; 37(8 Pt 2):2918-29. PubMed ID: 406041
    [No Abstract]   [Full Text] [Related]  

  • 4. Dose response relationship of methotrexate in combination with cisplatin in murine bladder cancer.
    Brausi M; Blatnik A; Soloway MS
    Urology; 1990 Mar; 35(3):253-6. PubMed ID: 2316090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single and combination chemotherapy for primary murine bladder cancer.
    Soloway MS
    Cancer; 1975 Aug; 36(2):333-40. PubMed ID: 1157004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The efficacy of chemotherapeutic agents against murine bladder metastasis.
    Klaunig JE; Barut BA
    J Urol; 1987 Dec; 138(6):1471-3. PubMed ID: 3682079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of platinum analogues and combination chemotherapy on murine bladder cancer.
    Soloway MS; Cox CE
    Trans Am Assoc Genitourin Surg; 1979; 71():8-13. PubMed ID: 545820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of single agent cisplatin and cisplatin containing combinations in treatment of murine bladder cancer.
    Hickey DP; Brausi M; Blatnik AF; Soloway MS
    Urology; 1987 Nov; 30(5):484-7. PubMed ID: 3118551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metastatic characteristics of four FANFT-induced murine bladder tumors.
    Crabtree WN; Soloway MS; Matheny RB; Murphy WM
    Urology; 1983 Nov; 22(5):529-31. PubMed ID: 6649210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro and in vivo activity of two second generation platinum analogs in murine bladder cancer.
    Niell HB; Herrod HG; Blatnik AF; Soloway MS
    J Urol; 1985 Aug; 134(2):399-402. PubMed ID: 3894702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemotherapy of experimental transitional-cell carcinoma.
    DeKernion JB; Soloway MS; Persky L
    Urology; 1974 Jul; 4(1):63-8. PubMed ID: 21322986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic chemotherapy of murine bladder cancer.
    Soloway MS; Niell HB; Matheny RB; Blatnik A
    Urology; 1984 Apr; 23(4 Suppl):129-34. PubMed ID: 6538713
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunogenicity of N-[-4-(5-nitro-2-furyl)-2-thiazolyl]formamide-induced bladder cancer.
    Soloway MS; Martino C; Hyatt C; Marrone JC
    Natl Cancer Inst Monogr; 1978 Dec; (49):293-300. PubMed ID: 748783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The synergistic effect of hyperthermia and chemotherapy on murine transitional cell carcinoma.
    Haas GP; Klugo RC; Hetzel FW; Barton EE; Cerny JC
    J Urol; 1984 Oct; 132(4):828-33. PubMed ID: 6540817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experimental bladder tumor induction, propagation, and therapy.
    Williams PD; Murphy GP
    Urology; 1976 Jul; 8(1):39-42. PubMed ID: 941358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth characteristics of N-[4-(5-nitro-2-furyl)-2-thiazolyl]-formamide (FANFT)-induced mouse bladder tumor lines in a human tumor stem cell assay.
    Niell HB; Mickey DD; Soloway MS; Wood CA
    Cancer; 1982 Jan; 49(2):323-30. PubMed ID: 7032684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro characterization of four N-[4-(5-nitro-2-furyl)-2-thiazolyl] formamide (FANFT) induced mouse bladder tumors.
    Mickey DD; Mickey GH; Murphy WM; Niell HB; Soloway MS
    J Urol; 1982 Jun; 127(6):1233-7. PubMed ID: 7087044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protection from carcinogen-induced murine bladder carcinoma by interferons and an oral interferon-inducing pyrimidinone, bropirimine.
    Borden EC; Sidky YA; Ertürk E; Wierenga W; Bryan GT
    Cancer Res; 1990 Feb; 50(4):1071-4. PubMed ID: 2297754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Time- and concentration-dependent inhibition of the clonogenic growth of N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide-induced murine bladder tumor cell lines by cis-diamminedichloroplatinum(II).
    Niell HB; Wood CA; Mickey DD; Soloway MS
    Cancer Res; 1982 Mar; 42(3):807-11. PubMed ID: 7199379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phototherapy of bladder cancer: dose/effect relationships.
    Haas GP; Shumaker BP; Hetzel FW; Bobrowski R; Lutz MD; Tilley B; Cerny JC
    J Urol; 1986 Aug; 136(2):525-8. PubMed ID: 2942706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.